Sensei Biotherapeutics, Inc.
Develops conditionally active antibodies for cancer targeting the tumor microenvironment.
SNSE | US
Overview
Corporate Details
- ISIN(s):
- US81728A1088
- LEI:
- Country:
- United States of America
- Address:
- 1405 RESEARCH BLVD, SUITE 125, 20850 ROCKVILLE
- Website:
- https://www.senseibio.com/
- Sector:
- Manufacturing
Description
Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company that discovers and develops next-generation therapeutics for cancer patients. The company's approach focuses on the tumor microenvironment (TME), developing conditionally active antibodies designed to function selectively within it. This strategy aims to create highly selective treatments against challenging immuno-oncology targets by leveraging the immune system's natural capabilities to combat cancer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Sensei Biotherapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Sensei Biotherapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Sensei Biotherapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||